GENE ONLINE|News &
Opinion
Blog

Servier
Trials & Approvals FDA ApprovalBrain TumorFirst-in-class
Servier’s $1.8 Billion Acquisition Pays Off: FDA Approves First-In-Class Treatment for Two Types of Rare Brain Cancer
2024-08-07
LATEST
Sprout Social Integrates Lumanu Payment Processing for Influencer Campaigns
2026-06-18
Hilton Partners With Big Brothers Big Sisters to Provide Hospitality Career Training for Youth
2026-06-18
Pacific Life Launches Income Horizon Collective Investment Trust Series for Retirement Plans
2026-06-18
Synovis Micro Companies Alliance to Distribute MediThinQ SHIYA 3D Visualization Platform Globally
2026-06-18
Diamond Estates Wines & Spirits Inc. Renews Investor Relations Agreement with Atrium Research
2026-06-18
Social Media Replaces Traditional Channels as Primary Tool for Corporate Crisis Management
2026-06-18
Life360 and Uber Partner to Allow Parents to Book and Track Rides Within the Life360 App
2026-06-18
READ MORE
EVENT
2026-06-22
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
2026-06-25
ASCO Breakthrough 2026 (Next-Gen Oncology Innovation)
Singapore
2026-06-25
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
2026-07-08
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
SEE MORE
Scroll to Top